Back to Newsroom

International Stem Cell Corporation Announces Launch Plans for New Nano-Compound Products

CARLSBAD, CA–(Marketwired – December 01, 2015) – International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that its wholly-owned subsidiary Lifeline Skin Care, Inc. (Lifeline) will launch its next generation skin care product based on a breakthrough nano-compound technology in time for December holiday season.

The initial launch of the Molecular Renewal SerumTM is expected in mid-December of 2015, when a retail version of the product will be available for purchase by US-based consumers through Lifeline’s website. Subsequent product launches will target the domestic professional sales market, which includes luxury spas, aestheticians, and medical offices, as well as luxury skincare markets in Europe and Asia.

Click here to read more